by Caitlin Kingsley | Dec 1, 2014 | Genetic Journal
It is well-known that women who carry a mutation in BRCA1 or BRCA2 are at high risk to develop breast cancer (50-85% lifetime risk) and ovarian cancer (15-60% lifetime risk). Because the screening options for ovarian cancer (transvaginal ultrasound, the blood test...
